1. Töpf, Ana, Johnson, Katherine, Bates, Adam, MacArthur, Daniel G, Straub, Volker. 2020. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness. In Genetics in medicine : official journal of the American College of Medical Genetics, 22, 1478-1488. doi:10.1038/s41436-020-0840-3. https://pubmed.ncbi.nlm.nih.gov/32528171/
2. Zhang, Yufeng, Niu, Yingzhen, Peng, Yonggang, Pan, Xueyang, Wang, Fei. 2023. COL3A1, COL5A1 and COL6A2 serve as potential molecular biomarkers for osteoarthritis based on weighted gene co‑expression network analysis bioinformatics analysis. In Experimental and therapeutic medicine, 26, 540. doi:10.3892/etm.2023.12239. https://pubmed.ncbi.nlm.nih.gov/37869636/
3. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
4. Cheon, Dong-Joo, Orsulic, Sandra. . Ten-gene biomarker panel: a new hope for ovarian cancer? In Biomarkers in medicine, 8, 523-6. doi:10.2217/bmm.14.16. https://pubmed.ncbi.nlm.nih.gov/24796616/
5. Zhu, Jinchao, Lin, Qingyuan, Zheng, Haiyan, Rao, Yamin, Ji, Tianhai. 2022. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. In Frontiers in oncology, 12, 897042. doi:10.3389/fonc.2022.897042. https://pubmed.ncbi.nlm.nih.gov/36505882/